A Clinical Trial to Evaluate the Safety and Pharmacokinetic
Status:
Unknown status
Trial end date:
2018-04-30
Target enrollment:
Participant gender:
Summary
A phase 1 clinical trail to evaluate the safety and pharmacokinetic characteristic after
administration of fixed-dose combination or loose combination of HUG186 in healthy adult male
or menopausal female volunteers